Less than 2 hours until the first Ignition Sale on Bio Season 2, @NEURONGale. Here’s everything you need to know 🧵↓

Mission Neuron Gale is testing a small molecule in an in vivo mouse model to uncover a novel treatment to brain inflammation in Alzheimer’s. If its Galectin-3 inhibition treatment proves effective, it could attain blockbuster drug status in a $1.44 trillion annual market.

Team Neuron Gale is led by a team of neuroscientists and biotech entrepreneurs, including: • Dr. Maryna Polyakova: Neuroscientist who leads the Neurotech Tree project at the Foresight Institute. • Dr. Peter Groenen: Biomarker & translational expert with 25 years of biopharma experience, having led numerous early research teams through late-stage R&D. • @Cerebrum_DAO: leading onchain research community backed by @BoostVC, advancing brain health research in various stages of drug screening & human trials.

Fundraising $GALE will leverage Bio’s new Milestone Funding mechanism, which unlocks funding as FDV milestones are reached and maintained for 2+ weeks. • Initial Raise: $50K • Starting FDV: $500K FDV • Total Potential Raise: $1.06M FDV Milestone 1: $1M Payout: $31K FDV Milestone 2: $2M Payout: $62K FDV Milestone 3: $4.2M Payout: $127K FDV Milestone 3: $8.6M Payout: $260K FDV Milestone 4: $17.7M Payout: $530K

Tokenomics → 10% allocated to the Ignition Sale → 5% allocated to Ecosystem Airdrop, automatically received by all $BIO stakers (veBIO holders) → Sale participants get 20% of their tokens liquid at TGE, while the remaining 80% vest linearly over the next 30 days

Neuron Gale Roadmap